Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1995-10-05
1997-03-25
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159, C07C 300
Patent
active
056145128
ABSTRACT:
A birth control method for a female mammal which comprises administering to the mammal an amount of a vitamin D compound sufficient to block binding of progesterone to the progesterone receptor in said mammal. The vitamin D compounds are 20-oxo-pregnacalciferol analogs, preferably 3-desoxy-20-oxo-19-nor-pregnacalciferol and its 2-oxo analog.
REFERENCES:
patent: 5397776 (1995-03-01), DeLuca et al.
Darwish Hisham M.
DeLuca Hector F.
Perlman Kato L.
Sicinski Rafal R.
Criares Theodore J.
Wisconsin Alumni Research Foundation
LandOfFree
20-Oxo-pregnacalciferol analogs with binding affinity to the pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 20-Oxo-pregnacalciferol analogs with binding affinity to the pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 20-Oxo-pregnacalciferol analogs with binding affinity to the pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203552